Coya Therapeutics, Inc. COYA Q1 2026 earnings

FAQ

When did Coya Therapeutics, Inc. report Q1 2026 earnings?

Coya Therapeutics, Inc. (COYA) reported Q1 2026 earnings on May 12, 2026 before market open.

What were Coya Therapeutics, Inc.'s Q1 2026 revenue and EPS?

Coya Therapeutics, Inc. reported revenue of $300.0K and eps of $-0.32 for Q1 2026.

Did Coya Therapeutics, Inc. beat estimates in Q1 2026?

Revenue beat the consensus estimate of $150.0K by $150.0K. EPS beat the consensus estimate of $-0.39 by $0.07.

How did Coya Therapeutics, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 16.3% from $257.9K a year earlier and eps grew 27.3% from $-0.44.

Where can I find Coya Therapeutics, Inc.'s Q1 2026 SEC filings?

You can read the 8-K earnings release (0001193125-26-218198) and the 10-Q periodic report (0001193125-26-218201) directly on SEC EDGAR. The filing index links above go to sec.gov.